What a Breast MRI Study Reveals About Axillary Lymph Nodes and COVID-19 Booster Vaccination
In a study of 128 patients who had breast magnetic resonance imaging (MRI) exams after COVID-19 booster vaccination, researchers noted that nearly 19 percent of the cohort had equal to or greater than 0.2 cm of increased lymph node cortical thickness.
Could Cardiac MRI Improve Risk Stratification in Patients with Dilated Cardiomyopathy?
Emerging research suggests that cardiac MRI findings of late gadolinium enhancement, native T1 values and extracellular volume fraction may predict sudden cardiac death-related events in patients with nonischemic dilated cardiomyopathy.
Looking at Next Steps to Reinforce National Breast Density Notification
In a recent video interview, Amy Patel, M.D., shared her perspective on forthcoming national beast density notification in mammography reporting, emphasized the importance of educating primary care providers on breast density risks, and discussed the ongoing need for coverage of supplemental options for breast cancer screening.
Gleamer's BoneView Gains FDA Clearance for AI-Powered Pediatric Fracture Detection
The artificial intelligence (AI)-enabled software, which has a documented 91 percent sensitivity rate for detecting pediatric fractures, is reportedly the first AI fracture detection modality to receive FDA 510(k) clearance for use in the pediatric population.
Seven Takeaways from Best Practice Recommendations for Incidental Radiology Findings in the ER
Noting that computed tomography (CT) scans are obtained for more than 30 million emergency department (ED) patients annually and that 31.3 percent of ED CT scans reveal incidental findings, representatives from the American College of Radiology (ACR) and the American College of Emergency Physicians (ACEP) recently collaborated on best practice recommendations for addressing incidental imaging findings in EDs.
Current Insights on National Breast Density Notification for Mammography Reports
In a recent video interview, Wendie Berg, M.D., Ph.D., discussed the newly issued final rule from the Food and Drug Administration (FDA) requiring a national standard for breast density notification (starting on September 10, 2024) as well as its potential impact in mammography reporting and facilitating supplemental screening for patients with dense breasts.
FDA Issues Final Rule on National Breast Density Notification for Mammography Reports
As part of updates to the Mammography Quality Standards Act (MQSA) of 1992, the Food and Drug Administration (FDA) has issued a final rule that requires the inclusion of breast density assessment in mammography reports starting on September 10, 2024.
New Chest CT Study Assesses Impact of COVID-19 Variants and Vaccination Status
Emerging research from a multicenter study found that COVID-19 vaccination was affiliated with a lower likelihood of high computed tomography (CT) severity scores and typical CT findings for COVID-19 in comparison to unvaccinated patients.